ATE143373T1 - Proteine, vakzine und nucleinsäuren - Google Patents
Proteine, vakzine und nucleinsäurenInfo
- Publication number
- ATE143373T1 ATE143373T1 AT90306154T AT90306154T ATE143373T1 AT E143373 T1 ATE143373 T1 AT E143373T1 AT 90306154 T AT90306154 T AT 90306154T AT 90306154 T AT90306154 T AT 90306154T AT E143373 T1 ATE143373 T1 AT E143373T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- vaccines
- proteins
- tbe
- sequence
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 101000633984 Homo sapiens Influenza virus NS1A-binding protein Proteins 0.000 abstract 3
- 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 abstract 3
- 208000004006 Tick-borne encephalitis Diseases 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP89305708 | 1989-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE143373T1 true ATE143373T1 (de) | 1996-10-15 |
Family
ID=8202711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90306154T ATE143373T1 (de) | 1989-06-06 | 1990-06-06 | Proteine, vakzine und nucleinsäuren |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0402116B1 (hu) |
| JP (1) | JPH03151878A (hu) |
| AT (1) | ATE143373T1 (hu) |
| CA (1) | CA2018332A1 (hu) |
| CZ (1) | CZ277921B6 (hu) |
| DD (1) | DD297997A5 (hu) |
| DE (1) | DE69028658T2 (hu) |
| FI (1) | FI902814A0 (hu) |
| HU (1) | HUT54306A (hu) |
| NO (1) | NO902491L (hu) |
| SK (1) | SK277781B6 (hu) |
| YU (1) | YU109590A (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
| FR2794865B1 (fr) * | 1999-06-09 | 2003-04-18 | Pasteur Institut | Methode de detection precoce des flavivirus et ses applications |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0284791B1 (de) * | 1987-03-20 | 1995-05-03 | IMMUNO Aktiengesellschaft | DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung |
| IL91304A0 (en) * | 1988-08-20 | 1990-03-19 | Us Health | Recombinant vaccinia virus for prevention of disease caused by flavivirus |
-
1990
- 1990-06-05 FI FI902814A patent/FI902814A0/fi not_active Application Discontinuation
- 1990-06-05 NO NO90902491A patent/NO902491L/no unknown
- 1990-06-05 DD DD90341327A patent/DD297997A5/de not_active IP Right Cessation
- 1990-06-05 YU YU109590A patent/YU109590A/sh unknown
- 1990-06-05 CA CA002018332A patent/CA2018332A1/en not_active Abandoned
- 1990-06-05 HU HU903490A patent/HUT54306A/hu unknown
- 1990-06-06 AT AT90306154T patent/ATE143373T1/de not_active IP Right Cessation
- 1990-06-06 CZ CS902806A patent/CZ277921B6/cs unknown
- 1990-06-06 SK SK2806-90A patent/SK277781B6/sk unknown
- 1990-06-06 JP JP2146403A patent/JPH03151878A/ja active Pending
- 1990-06-06 DE DE69028658T patent/DE69028658T2/de not_active Expired - Fee Related
- 1990-06-06 EP EP90306154A patent/EP0402116B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0402116B1 (en) | 1996-09-25 |
| HU903490D0 (en) | 1990-10-28 |
| NO902491D0 (no) | 1990-06-05 |
| JPH03151878A (ja) | 1991-06-28 |
| SK277781B6 (en) | 1995-01-05 |
| NO902491L (no) | 1990-12-07 |
| DD297997A5 (de) | 1992-01-30 |
| CZ277921B6 (en) | 1993-06-16 |
| DE69028658D1 (de) | 1996-10-31 |
| FI902814A0 (fi) | 1990-06-05 |
| CS9002806A2 (en) | 1991-11-12 |
| EP0402116A1 (en) | 1990-12-12 |
| HUT54306A (en) | 1991-02-28 |
| CA2018332A1 (en) | 1990-12-06 |
| DE69028658T2 (de) | 1997-03-06 |
| YU109590A (sh) | 1992-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3856141T2 (de) | Respiratorisches syncytiales virus, impstoffe | |
| DE3588254D1 (de) | Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen | |
| DE69630457D1 (de) | Verbindungen zur immunotherapie und diagnose von tuberkulose | |
| DE58906121D1 (de) | Rekombinantes Vaccinia-Virus MVA. | |
| BR9708401A (pt) | Vetores de vìrus de para-varìola | |
| DE69433690D1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
| KR970705408A (ko) | 헤모필루스 부착 및 침투 단백질(haemophilus adherence and penetration proteins) | |
| KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| ATE143373T1 (de) | Proteine, vakzine und nucleinsäuren | |
| PL307170A1 (en) | Vaccine against multicellular parasites | |
| ATE119166T1 (de) | An hiv relatierte peptide. | |
| DK43991D0 (da) | Allele varianter af plasmodium falciparum merozoitoverfladeantigen | |
| TH23725A (th) | วัคซีนป้องกันโรคบิดสำหรับสัตว์ปีก | |
| MY106940A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |